Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

Open accessibility options menu
  • 24/7
  • Buzz
  • Startups
  • VC
  • Finance@
  • Work@
  • Innovation
  • Opinions
  • Search
  • cleanSearch
  • Accesabillty
  • calcalist logo
bycalcalist logo
  • Homepage
  • Tags search
  • Entera

CTech 24/7

  • Intel’s Israeli workforce hits decade low as more layoffs loom
  • As Israeli tech ecosystem matures, the meaning of exit evolves
  • "It’s important to plan the vision from the very beginning"
  • “Selling the product is the easy part. Convincing people to believe in you is the hard part”
More stories in CTech

Entera

4 stories about Entera
  • Nasdaq. Photo: Shutterstock

    Drug Developer Entera Bio Down on Nasdaq Following Amgen Deal

    12.12.18|Lilach BaumerThe deal, announced Tuesday, could see Entera receive up to $270 million in aggregate payments

  • Drugs (illustration). Photo: Pexels/Pixabay

    Entera Bio Gives Nasdaq IPO Another Shot

    21.05.18|Dror ReichThis is the fourth time since 2014 that the Jerusalem-based biomed company files for an initial public offering on Nasdaq

  • Tel Aviv skyline. Photo: Bloomberg

    CTech’s Daily Israeli Tech News Roundup

    08.01.18|CTechIsraeli investment house to open crypto unit. A closer look at the first company funded by Koch’s new venture capital firm. Intuition Robotics expands funding round, nabbing Samsung as an investor.

  • Nasdaq. Photo: Nasdaq

    For the Fourth Time, Entera Bio Tries for Nasdaq IPO

    08.01.18|Dror ReichThe Jerusalem-based biomed company plans to raise $55 million, with Oppenheimer & Co. as the sole underwriter

Load more
Ctech Logo
Twitter
Twitter
Facebook
Facebook
NewsLetter
Newsletter
Contact Us
Contact Us
Rss
Rss
About CTech Terms of Use Privacy Policy
Developed by YIT UI & UX by Basch_Interactive